Being a company focused on Rare Diseases means that we don’t attract the attention other phramas do, with our small investor base, as mentioned above, funds and institutions can play as many games as they want with our share price.
I am abit shocked we have fallen this far, I thought we’d find a new floor around $15.00 but obviously the buys aren’t there atm.
Honestly who knows where we will end up by December but I will continue to hold and watch NEU hit milestone after milestone, I do hope 2591 has some larger disorders as a treatment to bring more awareness to our amazing company!
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$17.29 |
Change
0.660(3.97%) |
Mkt cap ! $2.178B | |||
| Open | High | Low | Value | Volume |
| $16.80 | $17.34 | $16.63 | $9.078M | 529.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1334 | $17.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.33 | 2245 | 3 |
View Market Depth
| Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |